Hologic, Inc. logo HOLX - Hologic, Inc.

Inactive Ticker HOLX is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 18
HOLD 23
SELL 1
STRONG
SELL
0
| PRICE TARGET: $78.69 DETAILS
HIGH: $95.00
LOW: $33.00
MEDIAN: $78.50
CONSENSUS: $78.69
UPSIDE: 3.53%

About Hologic, Inc. (https://www.hologic.com)

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Key Executives

NAME TITLE DOB SALARY
Stephen MacMillan Chairman, Chief Executive Officer & President 1964 $3,172,764 USD
Essex Mitchell Chief Operating Officer 1980 $1,531,047 USD
Jan Verstreken Group President of International 1969 $1,436,706 USD
Anne Liddy General Counsel 1976 $1,418,089 USD
Karleen Oberton Chief Financial Officer 1971 $1,356,103 USD
Jennifer Schneiders President of Diagnostic Solutions 1969 $1,109,366 USD
Benjamin Cohn Vice President & Corporate Controller
Brandon Schnittker President of GYN Surgical Solutions 1985
Diana De Walt SPHR Senior Vice President of Global Human Resources 1955
Mark Horvath President of Breast & Skeletal Health Solutions 1963
Mark Irving Vice President & Corporate Secretary
Michael J. Watts Corporate Vice President of Investor Relations
Monica Aguirre Berthelot Vice President & Chief of Staff
Paul Malenchini Chief Information Officer
Scott Christensen Senior Vice President of Global Supply Chain & Regulatory Affairs

Company Peers

Peer analysis pending, check back in 1-2 minutes.